BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 30087366)

  • 61. Downregulation of miR-497-5p prevents liver ischemia-reperfusion injury in association with MED1/TIMP-2 axis and the NF-κB pathway.
    Wu K; Tao G; Xu T; An Y; Yu X; Wang Y; Wang S; Guo W; Ma L
    FASEB J; 2021 Apr; 35(4):e21180. PubMed ID: 33715222
    [TBL] [Abstract][Full Text] [Related]  

  • 62. MiR-876-5p regulates gastric cancer cell proliferation, apoptosis and migration through targeting WNT5A and MITF.
    Xu Z; Yu Z; Tan Q; Wei C; Tang Q; Wang L; Hong Y
    Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31171711
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Estrogen regulates miRNA expression: implication of estrogen receptor and miR-124/AKT2 in tumor growth and angiogenesis.
    Jiang CF; Li DM; Shi ZM; Wang L; Liu MM; Ge X; Liu X; Qian YC; Wen YY; Zhen LL; Lin J; Liu LZ; Jiang BH
    Oncotarget; 2016 Jun; 7(24):36940-36955. PubMed ID: 27175587
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Let-7 family miRNAs regulate estrogen receptor alpha signaling in estrogen receptor positive breast cancer.
    Zhao Y; Deng C; Wang J; Xiao J; Gatalica Z; Recker RR; Xiao GG
    Breast Cancer Res Treat; 2011 May; 127(1):69-80. PubMed ID: 20535543
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Long non-coding RNA MIAT is estrogen-responsive and promotes estrogen-induced proliferation in ER-positive breast cancer cells.
    Li Y; Jiang B; Wu X; Huang Q; Chen W; Zhu H; Qu X; Xie L; Ma X; Huang G
    Biochem Biophys Res Commun; 2018 Sep; 503(1):45-50. PubMed ID: 29792859
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Circular RNA hsa_circ_0052112 promotes cell migration and invasion by acting as sponge for miR-125a-5p in breast cancer.
    Zhang HD; Jiang LH; Hou JC; Zhong SL; Zhou SY; Zhu LP; Li J; Wang DD; Sun DW; Ji ZL; Tang JH
    Biomed Pharmacother; 2018 Nov; 107():1342-1353. PubMed ID: 30257349
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Med19 is targeted by miR-101-3p/miR-422a and promotes breast cancer progression by regulating the EGFR/MEK/ERK signaling pathway.
    Zhang X; Gao D; Fang K; Guo Z; Li L
    Cancer Lett; 2019 Mar; 444():105-115. PubMed ID: 30583076
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Key roles for MED1 LxxLL motifs in pubertal mammary gland development and luminal-cell differentiation.
    Jiang P; Hu Q; Ito M; Meyer S; Waltz S; Khan S; Roeder RG; Zhang X
    Proc Natl Acad Sci U S A; 2010 Apr; 107(15):6765-70. PubMed ID: 20351249
    [TBL] [Abstract][Full Text] [Related]  

  • 69. miR-206 Expression is down-regulated in estrogen receptor alpha-positive human breast cancer.
    Kondo N; Toyama T; Sugiura H; Fujii Y; Yamashita H
    Cancer Res; 2008 Jul; 68(13):5004-8. PubMed ID: 18593897
    [TBL] [Abstract][Full Text] [Related]  

  • 70. MicroRNA-449b-5p suppresses the growth and invasion of breast cancer cells via inhibiting CREPT-mediated Wnt/β-catenin signaling.
    Jiang J; Yang X; He X; Ma W; Wang J; Zhou Q; Li M; Yu S
    Chem Biol Interact; 2019 Apr; 302():74-82. PubMed ID: 30738779
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Enforced expression of hsa-miR-125a-3p in breast cancer cells potentiates docetaxel sensitivity via modulation of BRCA1 signaling.
    Xu X; Lv YG; Yan CY; Yi J; Ling R
    Biochem Biophys Res Commun; 2016 Oct; 479(4):893-900. PubMed ID: 27693788
    [TBL] [Abstract][Full Text] [Related]  

  • 72. LncRNA LUCAT1/miR-181a-5p axis promotes proliferation and invasion of breast cancer via targeting KLF6 and KLF15.
    Liu Y; Cheng T; Du Y; Hu X; Xia W
    BMC Mol Cell Biol; 2020 Sep; 21(1):69. PubMed ID: 32998707
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Down-regulation of Forkhead box protein A1 (FOXA1) leads to cancer stem cell-like properties in tamoxifen-resistant breast cancer cells through induction of interleukin-6.
    Yamaguchi N; Nakayama Y; Yamaguchi N
    J Biol Chem; 2017 May; 292(20):8136-8148. PubMed ID: 28270510
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A miR-26a/E2F7 feedback loop contributes to tamoxifen resistance in ER-positive breast cancer.
    Liu J; Li X; Wang M; Xiao G; Yang G; Wang H; Li Y; Sun X; Qin S; Du N; Ren H; Pang Y
    Int J Oncol; 2018 Oct; 53(4):1601-1612. PubMed ID: 30066905
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Downregulation of miR-193b contributes to enhance urokinase-type plasminogen activator (uPA) expression and tumor progression and invasion in human breast cancer.
    Li XF; Yan PJ; Shao ZM
    Oncogene; 2009 Nov; 28(44):3937-48. PubMed ID: 19701247
    [TBL] [Abstract][Full Text] [Related]  

  • 76. miR-219-5p modulates cell growth of papillary thyroid carcinoma by targeting estrogen receptor α.
    Huang C; Cai Z; Huang M; Mao C; Zhang Q; Lin Y; Zhang X; Tang B; Chen Y; Wang X; Qian Z; Ye L; Peng Y; Xu H
    J Clin Endocrinol Metab; 2015 Feb; 100(2):E204-13. PubMed ID: 25423566
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Circular RNA hsa_circ_0008039 promotes breast cancer cell proliferation and migration by regulating miR-432-5p/E2F3 axis.
    Liu Y; Lu C; Zhou Y; Zhang Z; Sun L
    Biochem Biophys Res Commun; 2018 Jul; 502(3):358-363. PubMed ID: 29807010
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Epigenetic-induced repression of microRNA-205 is associated with MED1 activation and a poorer prognosis in localized prostate cancer.
    Hulf T; Sibbritt T; Wiklund ED; Patterson K; Song JZ; Stirzaker C; Qu W; Nair S; Horvath LG; Armstrong NJ; Kench JG; Sutherland RL; Clark SJ
    Oncogene; 2013 Jun; 32(23):2891-9. PubMed ID: 22869146
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Aryl hydrocarbon-estrogen alpha receptor-dependent expression of miR-206, miR-27b, and miR-133a suppress cell proliferation and migration in MCF-7 cells.
    Mobini K; Tamaddon G; Fardid R; Keshavarzi M; Mohammadi-Bardbori A
    J Biochem Mol Toxicol; 2019 Jun; 33(6):e22304. PubMed ID: 30779469
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Neo-tanshinlactone selectively inhibits the proliferation of estrogen receptor positive breast cancer cells through transcriptional down-regulation of estrogen receptor alpha.
    Lin W; Huang J; Liao X; Yuan Z; Feng S; Xie Y; Ma W
    Pharmacol Res; 2016 Sep; 111():849-858. PubMed ID: 27491559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.